ZAI LAB (09688.HK): grants 5,900 options, 16,900 RSUs
- The grant date is 9 November 2026 (US Eastern Time), with each ADS representing 10 shares.
- The closing price on the grant date was USD 26.86 per ADS on Nasdaq.
NewTimeSpace News: On 10 November 2026, Zai Lab Limited (stock code: 09688) announced grants of options and restricted share units under its 2024 equity incentive plan on the grant date of 9 November 2026 (US Eastern Time), under Rules 17.06A, 17.06B and 17.06C. It granted 5,900 options, in American Depositary Shares, to two employee participants, covering 59,000 shares, at an exercise price of USD 26.86 per ADS, or about HKD 20.95 per share.
A further 16,900 restricted share units, covering 169,000 shares, went to six employee participants at nil purchase price. Both awards vest 25% on each anniversary of the grant date over four years, with the options valid for ten years and neither award subject to performance targets or clawback. Some 61,687,193 shares remain available for future grant under the plan mandate.
- ZAI LAB (09688.HK): Zoci Plus Atezolizumab in First-Line ES-SCLC Yields 81.8% Confirmed ORR
- HK Stock Connect Daily Report: Nexchip formally added to HK Stock Connect, innovative drug sector driven by dense earnings catalysts - 20260807
- Zai Lab (09688.HK): Grant of Share Options and Restricted Share Units
- ZAI LAB(09688.HK)2026 Q1 Report - Profit Attributable to Shareholders stood at loss of USD 51.02 million, loss widened by 5.32% YoY
